Abstract
The current trial assessed whether the addition of cisplatin and capecitabine to the nab-paclitaxel-gemcitabine backbone is feasible and active against borderline and locally advanced pancreatic adenocarcinoma (PDAC). Fifty-four chemo-naive patients, aged between 18 and 75 years, with a pathological diagnosis of locally advanced or borderline resectable PDAC were randomised to receive either nab-paclitaxel, gemcitabine, cisplatin and oral capecitabine (PAXG; arm A; N = 26) or nab-paclitaxel followed by gemcitabine (AG; arm B; N = 28). The primary end-point was the tumour resection rate. If at least four such resections were performed, the treatment was considered as active. The secondary end-points were progression-free survival (PFS), overall survival (OS), Response Evaluation Criteria in Solid Tumours response rate, Hartman's pathologic response, carbohydrate antigen 19.9 response rate and toxicity. Eight patients (31%) in the PAXG arm and nine (32%) in the AG arm underwent resection. PFS at 1-year was 58% in arm A and 39% in arm B. OS at 18-month was 69% in arm A and 54% in arm B. In this phase II study, the addition of cisplatin and capecitabine to the AG backbone was feasible and yielded promising results in terms of disea...Continue Reading
Citations
Nov 14, 2019·Journal of Clinical Medicine·Ester Oneda, Alberto Zaniboni
Feb 6, 2020·Pancreas·Satoshi KobayashiManabu Morimoto
Oct 11, 2019·Therapeutic Advances in Medical Oncology·Aurélien LambertThierry Conroy
Nov 9, 2019·Scientific Reports·Akiko TsujimotoTaketo Yamaguchi
Dec 19, 2019·Frontiers in Oncology·Nicolò PecorelliGianpaolo Balzano
Mar 31, 2020·Annals of Surgical Oncology·Alessandro PanicciaAmer H Zureikat
Nov 14, 2019·Journal of Clinical Medicine·Thomas Hank, Oliver Strobel
Mar 12, 2020·Cancer Chemotherapy and Pharmacology·Michele ReniLuca Gianni
Dec 4, 2019·Frontiers in Oncology·Mengxi ZhangQiu Li
Apr 4, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Stefano CascinuFrancesco Perrone
Apr 17, 2021·Endoscopy·Giuseppe VanellaPaolo Giorgio Arcidiacono
Aug 27, 2019·Annals of Surgery·Bradley N ReamesJin He
Jul 29, 2021·Esophagus : Official Journal of the Japan Esophageal Society·Zhiqiang WangYuhong Li
Aug 28, 2021·Biomolecules·Alessandro PassardiAntonino Romeo
Sep 14, 2021·Journal of Hepato-biliary-pancreatic Sciences·Ning PuWenhui Lou
Nov 11, 2021·Small·Mubin TarannumJuan L Vivero-Escoto